| 1 |
33438851 | Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals. | 2022 Feb |
1 |
| 2 |
31383827 | The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study. | 2019 Apr |
1 |
| 3 |
29254684 | Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. | 2018 Nov |
1 |
| 4 |
30383478 | Predictive value of IL-28B rs12979860 variants for peg-IFN, sofosbuvir plus ribavirin treatment of HCV infection in Pakistani population. | 2018 Nov |
1 |
| 5 |
30450628 | IL-28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients. | 2018 Nov 18 |
1 |
| 6 |
28852525 | Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism. | 2017 Aug |
2 |
| 7 |
26825765 | Peginterferon Therapy in Children With Chronic Hepatitis C: A Nationwide, Multicenter Study in Japan, 2004-2013. | 2016 Jul |
2 |
| 8 |
27110259 | The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C. | 2016 Jan |
1 |
| 9 |
27541605 | Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy. | 2016 Dec |
1 |
| 10 |
24517415 | Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B. | 2015 Feb |
1 |
| 11 |
25958342 | The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C. | 2015 Aug 15 |
1 |
| 12 |
26060059 | Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment. | 2015 Aug |
2 |
| 13 |
26284971 | Effect of IL28B genotype on hepatitis B and C virus infection. | 2015 Oct |
1 |
| 14 |
26526510 | Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients. | 2015 Sep-Dec |
1 |
| 15 |
23591768 | Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients. | 2014 Jan |
5 |
| 16 |
23841718 | Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C. | 2014 Oct |
2 |
| 17 |
24316030 | Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon. | 2014 Feb |
1 |
| 18 |
24325405 | Role of IL28B for chronic hepatitis C treatment toward personalized medicine. | 2014 Feb |
2 |
| 19 |
24338811 | Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients. | 2014 Feb |
3 |
| 20 |
24523350 | Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients. | 2014 |
1 |
| 21 |
24642705 | IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis. | 2014 |
1 |
| 22 |
24654629 | Review article: genetic factors that modify the outcome of viral hepatitis. | 2014 May |
1 |
| 23 |
24750345 | ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type. | 2014 Jul |
1 |
| 24 |
25013899 | Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients. | 2014 |
1 |
| 25 |
25032184 | No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients. | 2014 Jun |
1 |
| 26 |
25328696 | Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks. | 2014 |
1 |
| 27 |
25337144 | The role of interleukin-28b gene polymorphisms in chinese patients with chronic hepatitis C treated with pegylated interferon and ribavirin. | 2014 Aug |
2 |
| 28 |
25393304 | Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. | 2014 |
1 |
| 29 |
25469117 | Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients. | 2014 Nov |
1 |
| 30 |
23314745 | Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4. | 2013 Jun |
1 |
| 31 |
23383658 | HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism. | 2013 Mar |
1 |
| 32 |
23440114 | Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene. | 2013 Feb |
1 |
| 33 |
23542783 | Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response. | 2013 Jul |
1 |
| 34 |
23715768 | Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection. | 2013 Nov |
1 |
| 35 |
23842134 | Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection. | 2013 Nov 13 |
1 |
| 36 |
23918536 | Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b. | 2013 Jul |
1 |
| 37 |
23967025 | Serum lipoprotein profiles and response to pegylated interferon plus ribavirin combination therapy in patients with chronic HCV genotype 1b infection. | 2013 May |
1 |
| 38 |
21325786 | Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatment. | 2012 |
1 |
| 39 |
21879313 | Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C. | 2012 Jan |
2 |
| 40 |
21932415 | Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4. | 2012 Feb |
1 |
| 41 |
21990051 | Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4. | 2012 Jan |
1 |
| 42 |
22052088 | Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection. | 2012 Feb |
2 |
| 43 |
22108195 | Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. | 2012 Mar |
1 |
| 44 |
22212576 | IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late? | 2012 Feb |
2 |
| 45 |
22313623 | The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. | 2012 Feb 7 |
3 |
| 46 |
22350701 | IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. | 2012 Jul |
1 |
| 47 |
22382144 | LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients. | 2012 May 15 |
1 |
| 48 |
22649509 | IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. | 2012 |
1 |
| 49 |
22967098 | Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection? | 2012 Oct |
2 |
| 50 |
23080496 | A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy. | 2012 Dec |
1 |